Table 4.
Multivariate analysis showing the associated predictors of rifampicin resistant M. tuberculosis in DMRH, 2015
| Variables | Resistance pattern | AOR (95% CI) | P value | |
|---|---|---|---|---|
| Resistance | Sensitive | |||
| Age, years | ||||
| 0–10 | 2 | 7 | 2.3 (0.15–37.67) | 0.55 |
| 11–17 | 1 | 6 | 1.84 (0.08–44.6) | 0.71 |
| 18–30 | 3 | 43 | 0.55 (0.04–6.80) | 0.64 |
| 31–40 | 0 | 25 | ||
| 41–50 | 5 | 10 | 4.3 (0.34–54.99) | 0.23 |
| 51–60 | 0 | 9 | ||
| 61–92 | 1 | 5 | a | |
| HIV infection | ||||
| Positive | 5 | 24 | 3.2 (0.69–14.96) | 0.14 |
| Negative | 7 | 81 | a | |
| Reason for examination | ||||
| Presumptive TB | 3 | 49 | a | |
| Presumptive DR TB | 9 | 56 | 0.41 (10.04–4.21) | 0.45 |
| Treatment history with anti-TB drugs | ||||
| Previously treated | 7 | 34 | 4.16 (1.04–16.63) | 0.04 |
| Previously untreated | 5 | 71 | a | |
DR TB drug resistant tuberculosis, AOR adjusted odds ratio, CI confidence interval
aReference category, Hosmer–Lemeshow test = 0.99, Pearson Chi-square = 0.91, classification table = 89.7